Trial Profile
A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Tigatuzumab (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Pharmacokinetics
- 21 Oct 2010 New trial record